AAAAAA
Results: 1-25/167
Authors:
BEIN G
DRILLER B
SCHURMANN M
SCHNEIDER PM
KIRCHNER H
Citation: G. Bein et al., PSEUDO-EXCLUSION FROM PATERNITY DUE TO MATERNAL UNIPARENTAL DISOMY-16, International journal of legal medicine, 111(6), 1998, pp. 328-330
Authors:
KORTE S
AROLT V
PETERS M
WEITZSCH C
ROTHERMUNDT M
KIRCHNER H
Citation: S. Korte et al., INCREASED SERUM NEOPTERIN LEVELS IN ACUTELY ILL AND RECOVERED SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 32(1), 1998, pp. 63-67
Authors:
ROTHERMUNDT M
AROLT V
WEITZSCH C
KIRCHNER H
Citation: M. Rothermundt et al., IS SCHIZOPHRENIA AN AUTOIMMUNE-DISEASE, Schizophrenia research, 29(1-2), 1998, pp. 98-98
Authors:
HINTERMEIER C
KIRCHNER C
KIRCHNER H
Citation: C. Hintermeier et al., DYNAMICALLY TYPED COMPUTATIONS FOR ORDER-SORTED EQUATIONAL PRESENTATIONS, Journal of symbolic computation, 25(4), 1998, pp. 455-526
Authors:
BOKEMEYER C
HARSTRICK A
BEYER J
METZNER B
RUTHER U
HARTMANN JT
HOLSTEIN K
DERIGS HG
DEWIT R
CASPER J
SCHOFFSKI P
KUHRER I
ILLIGER HJ
KEMPF B
REICHLE A
FOLLER A
HOSSFELD DK
FISCHER JT
BERDEL W
GERHARTZ H
KIRCHNER H
PFLUGER K
OSTERMANN H
KANZ L
SCHMOLL HJ
Citation: C. Bokemeyer et al., FIRST-LINE HIGH-DOSE CHEMOTHERAPY FOR POOR-RISK METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Onkologie, 21, 1998, pp. 23-25
Authors:
WANDINGER KP
BUBEL S
HENNIG H
SIEKHAUS A
TRILLENBERG P
WESSEL K
KIRCHNER H
Citation: Kp. Wandinger et al., ASSOCIATION BETWEEN DISEASE-ACTIVITY AND EPSTEIN-BARR-VIRUS REACTIVATION IN MULTIPLE-SCLEROSIS PATIENTS, Annals of neurology, 44(3), 1998, pp. 174-174
Authors:
KIRCHNER GI
FRANZKE A
BUER J
BEIL W
PROBSTKEPPER M
WITTKE F
OVERMANN K
LASSMANN S
HOFFMANN R
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: Gi. Kirchner et al., PHARMACOKINETICS OF RECOMBINANT HUMAN INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA PATIENTS FOLLOWING SUBCUTANEOUS APPLICATION, British journal of clinical pharmacology, 46(1), 1998, pp. 5-10
Authors:
KIRCHNER H
Citation: H. Kirchner, TREES IN ALGEBRA AND PROGRAMMING, Theoretical computer science, 190(1), 1998, pp. 1-2
Authors:
HENNIG H
WESSEL K
SONDERMEIJER P
KIRCHNER H
WANDINGER KP
Citation: H. Hennig et al., LACK OF EVIDENCE FOR MAREKS-DISEASE VIRUS GENOMIC SEQUENCES IN LEUKOCYTE DNA FROM MULTIPLE-SCLEROSIS PATIENTS IN GERMANY, Neuroscience letters, 250(2), 1998, pp. 138-140
Authors:
ROTHERMUNDT M
AROLT V
WEITZSCH C
ECKHOFF D
KIRCHNER H
Citation: M. Rothermundt et al., IMMUNOLOGICAL DYSFUNCTION IN SCHIZOPHRENIA - A SYSTEMATIC-APPROACH, Neuropsychobiology, 37(4), 1998, pp. 186-193
Authors:
ALVAREZOSSORIO L
JOHANNSEN M
ALVAREZOSSORIO R
NICKLAS W
KIRCHNER H
RINK L
Citation: L. Alvarezossorio et al., CYTOKINE INDUCTION BY MYCOPLASMA ARTHRITIDIS-DERIVED SUPERANTIGEN (MAS), BUT NOT BY TSST-1 OR SEC-3, IS CORRELATED TO CERTAIN HLA-DR TYPES, Scandinavian journal of immunology, 47(1), 1998, pp. 43-47
Authors:
SCHLENKE P
FROHN C
KLUTER H
SABALLUS M
HAMMERS HJ
ZAJAC SR
KIRCHNER H
Citation: P. Schlenke et al., EVALUATION OF A FLOW CYTOMETRIC METHOD FOR SIMULTANEOUS LEUKOCYTE PHENOTYPING AND QUANTIFICATION BY FLUORESCENT MICROSPHERES, Cytometry, 33(3), 1998, pp. 310-317
Authors:
BOKEMEYER C
HARSTRICK A
BEYER J
METZNER B
RUTHER U
HARTMANN JT
HOLSTEIN K
DERIGS HG
DEWIT R
CASPER J
SCHOFFSKI P
KUHRER I
ILLIGER HJ
KEMPF B
REICHLE A
FOLLER A
HOSSFELD DK
FISCHER JT
BERDEL WE
GERHARTZ HH
KIRCHNER H
PFLUGER KH
OSTERMANN H
KANZ L
SCHMOLL HJ
Citation: C. Bokemeyer et al., THE USE OF DOSE-INTENSIFIED CHEMOTHERAPY IN THE TREATMENT OF METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Seminars in oncology, 25(2), 1998, pp. 24-32
Authors:
RINK L
CAKMAN I
KIRCHNER H
Citation: L. Rink et al., ALTERED CYTOKINE PRODUCTION IN THE ELDERLY, Mechanism of ageing and development, 102(2-3), 1998, pp. 199-209
Authors:
JANETZKO K
BOCHER R
KLOTZ KF
KIRCHNER H
KLUTER H
Citation: K. Janetzko et al., EFFECTS OF BLOOD DONATION ON THE PHYSICAL-FITNESS AND HEMORHEOLOGY OFHEALTHY ELDERLY DONORS, Vox sanguinis, 75(1), 1998, pp. 7-11
Authors:
MULLERSTEINHARDT M
KIRCHNER H
KLUTER H
Citation: M. Mullersteinhardt et al., IMPACT OF STORAGE AT 22-DEGREES-C AND CITRATE ANTICOAGULATION ON THE CYTOKINE SECRETION OF MONONUCLEAR LEUKOCYTES, Vox sanguinis, 75(1), 1998, pp. 12-17
Authors:
WANDINGER KP
REISSLAND P
KIRCHNER H
WESSEL K
OTTO M
Citation: Kp. Wandinger et al., PRODUCTION OF ENDOGENOUS INTERFERON-ALPHA AND INTERFERON-BETA IN PATIENTS WITH MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 64(2), 1998, pp. 277-278
Authors:
FROHN C
SCHLENKE P
EBEL B
DANNENBERG C
BEIN G
KIRCHNER H
Citation: C. Frohn et al., DNA TYPING FOR NATURAL-KILLER-CELL INHIBITING HLA-CW GROUPS NK1 AND NK2 BY PCR-SSP, Journal of immunological methods, 218(1-2), 1998, pp. 155-160
Authors:
DUDA GN
KIRCHNER H
WILKE HJ
CLAES L
Citation: Gn. Duda et al., A METHOD TO DETERMINE THE 3-D STIFFNESS OF FRACTURE FIXATION DEVICES AND ITS APPLICATION TO PREDICT INTER-FRAGMENTARY MOVEMENT, Journal of biomechanics, 31(3), 1998, pp. 247-252
Authors:
KRAUTER J
PETER W
PASCHEBERG U
HEINZE B
BERGMANN L
HOELZER D
LUBBERT M
SCHLIMOK G
ARNOLD R
KIRCHNER H
PORT M
GANSER A
HEIL G
Citation: J. Krauter et al., DETECTION OF KARYOTYPIC ABERRATIONS IN ACUTE MYELOBLASTIC-LEUKEMIA - A PROSPECTIVE COMPARISON BETWEEN PCR FISH AND STANDARD CYTOGENETICS IN140 PATIENTS WITH DE-NOVO AML/, British Journal of Haematology, 103(1), 1998, pp. 72-78
Authors:
KLUTER H
GERMER U
GORTNER L
KIRCHNER H
GEMBRUCH U
Citation: H. Kluter et al., COINCIDENCE OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA AND MATERNAL ANTI-D IMMUNIZATION - CASE-REPORT, British Journal of Haematology, 102(5), 1998, pp. 1383-1384
Authors:
FENCHEL K
HOFFMANN R
BORGHARDT J
KIRCHNER H
PRALLE H
GANSER A
ATZPODIEN J
Citation: K. Fenchel et al., INTERLEUKIN-2 REDUCES THE CD4+ CELL DEPLETION FOLLOWING FLUDARABINE AND IDARUBICIN COMBINATION THERAPY, British Journal of Haematology, 102(1), 1998, pp. 89-89
Authors:
KRAUTER J
PASCHEBERG U
HEINZE B
BERGMANN L
HOELZER D
LUBBERT M
SCHLIMOK G
ARNOLD R
KIRCHNER H
PORT M
GANSER A
HELL G
Citation: J. Krauter et al., DETECTION OF CHROMOSOMAL-ABERRATIONS IN AML - COMPARISON OF RT-PCR FISH WITH STANDARD CYTOGENETICS/, British Journal of Haematology, 102(1), 1998, pp. 98-98
Authors:
HOFFMANN R
MULLER I
NEUBER K
LASSMANN S
BUER J
PROBST M
OEVERMANN K
FRANZKE A
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: R. Hoffmann et al., RISK AND OUTCOME IN METASTATIC MALIGNANT-MELANOMA PATIENTS RECEIVING DTIC, CISPLATIN, BCNU AND TAMOXIFEN FOLLOWED BY IMMUNOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON ALPHA2A, British Journal of Cancer, 78(8), 1998, pp. 1076-1080
Authors:
NEUBER K
KIRCHNER H
ATZPODIEN J
Citation: K. Neuber et al., TREATMENT OF METASTATIC MALIGNANT-MELANOMA WITH DTIC, CISPLATIN, BCNU, AND TAMOXIFEN FOLLOWED BY IMMUNOTHERAPY WITH IL-2 AND IFN-ALPHA, British Journal of Cancer, 77, 1998, pp. 76-76